drugset / Trial / NCT01823159
Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study
Phase 3
Completed
15 enrolled
University Hospital of Mont-Godinne
GlaxoSmithKline · collabUniversité Catholique de Louvain · collab
RandomizedCrossoverQuadruple-blindBasic science
Summary
The objective of this study is to characterize the effects of a single-dose of retigabine on cortical excitability in healthy subjects, as quantified by means of TMS.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-12
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ezogabine | Small molecule | 400 mg | Oral |